TY - JOUR
T1 - Perianal Fistulizing Crohn's Disease
T2 - Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care
AU - Hanna, Luke N.
AU - Anandabaskaran, Sulak
AU - Iqbal, Nusrat
AU - Geldof, Jeroen
AU - LeBlanc, Jean Frédéric
AU - Dige, Anders
AU - Lundby, Lilli
AU - Vermeire, Séverine
AU - D'Hoore, André
AU - Verstockt, Bram
AU - Bislenghi, Gabriele
AU - De Looze, Danny
AU - Lobaton, Triana
AU - Van de Putte, Dirk
AU - Spinelli, Antonino
AU - Carvello, Michele
AU - Danese, Silvio
AU - Buskens, Christianne J.
AU - Gecse, Krisztina
AU - Hompes, Roel
AU - Becker, Marte
AU - van der Bilt, Jarmila
AU - Bemelman, Willem
AU - Sebastian, Shaji
AU - Moran, Gordan
AU - Lightner, Amy L.
AU - Wong, Serre Yu
AU - Colombel, Jean Frédéric
AU - Cohen, Benjamin L.
AU - Holubar, Stefan D.
AU - Ding, Nik S.
AU - Behrenbruch, Corina
AU - Sahnan, Kapil
AU - Misra, Ravi
AU - Lung, Phillip
AU - Hart, Ailsa
AU - Tozer, Phil
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/5
Y1 - 2025/5
N2 - Background & Aims: Perianal fistulation is a challenging phenotype of Crohn's disease, with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalized, with lack of attention to the clinical heterogenicity seen. The recent ‘TOpClass classification system’ for perianal fistulizing Crohn's disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals. In this article, we discuss the clinical applicability of the TOpClass model and provide direction on its use in clinical practice. Methods: An international group of perianal clinicians participated in an expert consensus to define how the TOpClass system can be incorporated into real-life practice. This included gastroenterologists, inflammatory bowel disease surgeons, and radiologists specialized in PFCD. The process was informed by the multi-disciplinary team management of 8 high-volume fistula centres in North America, Europe, and Australia. Results: The process produced position statements to accompany the classification system and guide PFCD management. The statements range from the management of patients with quiescent perianal disease to those with severe PFCD requiring diverting-ostomy and/or proctectomy. The optimization of medical therapies, as well as the use of surgery, in fistula closure and symptom management is explored across each classification group. Conclusion: This article provides an overview of the system's use in clinical practice. It aims to enable clinicians to have a pragmatic and patient goal-centered approach to medical and surgical management options for individual patients with PFCD.
AB - Background & Aims: Perianal fistulation is a challenging phenotype of Crohn's disease, with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalized, with lack of attention to the clinical heterogenicity seen. The recent ‘TOpClass classification system’ for perianal fistulizing Crohn's disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals. In this article, we discuss the clinical applicability of the TOpClass model and provide direction on its use in clinical practice. Methods: An international group of perianal clinicians participated in an expert consensus to define how the TOpClass system can be incorporated into real-life practice. This included gastroenterologists, inflammatory bowel disease surgeons, and radiologists specialized in PFCD. The process was informed by the multi-disciplinary team management of 8 high-volume fistula centres in North America, Europe, and Australia. Results: The process produced position statements to accompany the classification system and guide PFCD management. The statements range from the management of patients with quiescent perianal disease to those with severe PFCD requiring diverting-ostomy and/or proctectomy. The optimization of medical therapies, as well as the use of surgery, in fistula closure and symptom management is explored across each classification group. Conclusion: This article provides an overview of the system's use in clinical practice. It aims to enable clinicians to have a pragmatic and patient goal-centered approach to medical and surgical management options for individual patients with PFCD.
KW - Crohn's Disease
KW - Multi-disciplinary Management
KW - Perianal Fistula
UR - https://www.scopus.com/pages/publications/105002495272
U2 - 10.1016/j.cgh.2024.06.047
DO - 10.1016/j.cgh.2024.06.047
M3 - Review article
AN - SCOPUS:105002495272
SN - 1542-3565
VL - 23
SP - 914
EP - 926
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 6
ER -